Skip to search formSkip to main contentSkip to account menu

abobotulinumtoxinA

Known as: abobotulinum toxin A, abobotulinumtoxin A 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (1)

Botulinum Toxin Type A

Narrower (2)

Dysportazzalure
abobotulinumtoxinA 300 UNT Injection [Dysport]abobotulinumtoxinA 500 UNT Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow’s Feet Wrinkles: A Split-Face Study
ABSTRACT Purpose: Comparing the clinical efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A(ONA) using a dosing ratio… 
2018
2018
[Botulinum toxin in treatment of lower limb spasticity in patients with brain damage].
AIM To develop and test a method of examination of patients with lower limb spasticity, to describe lower limb spasticity… 
2018
2018
Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia
Oromandibular dystonia (OMD) causes involuntary movements of masticatory and lingual muscles impairing eating, speaking, and… 
2017
2017
Mild to Moderate Dysphagia Following Very Low-dose Abobotulinumtoxin A for Platysmal Bands.
Onabotulinumtoxin A (Botox) can be a safe and successful off-label treatment of vertical platysma bands of various severities… 
2016
2016
Advancements and Refinement in Facial Neuromodulators
Summary: The use of neuromodulators has increased by approximately 748 percent from 2000 to 2014 and has become an integral… 
2015
2015
Fields of Anhidrotic Effects of AbobotulinumtoxinA in Patients With Compensatory Hyperhidrosis
BACKGROUND Botulinum toxin type A can be used to treat compensatory hyperhidrosis (CHH), which presents areas of different… 
Review
2015
Review
2015
Commentary on: Randomized Split-Face Study to Assess the Efficacy and Safety of AbobotulinumtoxinA Versus OnabotulinumtoxinA in the Treatment of Melomental Folds (Depressor Anguli Oris).
This study is the first to compare onabotulinumtoxinA (ONA) and abobotulinumtoxinA (ABO)—the most frequently used cosmetic… 
2012
2012
Is there a direct antimicrobial effect of botulinum neurotoxin type A?
Study Type – Therapy (case series) 
2011
2011
Should we stop using botulinum neurotoxin type a in patients with neurogenic detrusor overactivity after development of secondary resistance?
2010
2010
Gateways to clinical trials.
A-3309, Abobotulinumtoxin A, Adalimumab, AIDSVAX gp120 B/E, ALVAC E120TMG, Atorvastatin calcium; Bepridil, Bevacizumab… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)